You are on page 1of 12
« _ Camlin Fine Sciences Lid. Date: 23/05/2016 To, BSE Limited, 25, P. J. Towers, Dalal Street, Mumbai - 400 001 Ref: Company Scrip Code: 532834 To, The Manager, sting Depertment, National Stock Exchange of India Ltd., Exchange Plaza, Bondra Kurla Complex, Bandra (East), Mumbai- 400057 Ref: Symbol: CAMLINFINE | | Series: EQ Sub: Outcome of the Board Meeting The Board of Directors of the Company at its meeting held today i.e., 23¢ May, 2016, inter alic, has approved the following: |. The Audited Financial Results for the quorter and year ended 31st March, 2016. 2, Recommended dividend @ 45% (Rs. 0.45 per share) for the year 2015-2016, which would be paid subject to ihe shareholders approval. 3, Re-appointment of Mr, Dattatraya R. Puranik as Executive Director & CFO of the Company for a petiod of 3 years w.e.f. 01% August, 2016, subject fo the approval of shareholders at the ensuing Annual General Meeting of the Company. 4. Re-aopointment of M/s. B. K. Khare & Co., Chartered Accountants as the statutory auditors of the Company subject to the approval of shareholders at the ensuing Annual General Meeting of the Company. Kindly take the above information on records, Thanking You, For Camlin Fine Sciences Limited fee" Ghul D. Sawale Group Company Secretary (Rs in Lak, except per share data} Plot No. F/11 & F/12, WICEL, Opp. SEEPZ Main Gate, Cenirl Road, Anche (E}, Mumbci-400 093, Ini. Ts +491 22 6700 1000 | F: +91 22 2832 4404 | E corporate@comlings.com | voncomlings.com ‘Camlin Fine Sciences Ltd. Pt BF cami No. PARTICULARS. [Goss Sales/ncome from Operations |p) Total Expenditure (a+b+e+d+e+t) [Profit from Operations before Other Income, fand Exceptional tem (12) fotner Income Profit From ordinary 2 exceptional ems (3+4) finterest [Prosi ater reat but before Exceptional Items (6) jonal Items (refer note 203) is from Ordinary Activities before tax (7-8) Net Profit after Minority Share of PL Paid-up Equity Share Capital (Face Value Rs:/- per share) Reserves exciuding Revaluation yeas) earnings per Share (EPS) Basic (Rs) [Ditutod Re) STANDALON= CONSOLIDATED (Quarter Hae Year Bde Quarter Ended Year Ended 31.05.2015 sLaams arizams | scans [amc] scans inated) ‘Budited) Gi i G5 “4024.09 12023] sas} 166.68 1,280.23 3967-1 ao73as| ios1] ssiso} 1445310 35,512.45 188.62 wear} 10326) 19470 - 284.99 ross7si| 1051.03 sane | 1303577) 1205920) 4453.10 5580745 azsesn| — 7as25} 162730] sa] essay! asian] rare] rear2] sy sscoss] satan | 7,0e198] 2ss012] r6seiz| 7rais2] 39300] 3.71590] 2eo7s4a] asaar.es 680.79 10.75] e244] 136408] 242817 e749} 15370 785) 750.76 90.79 72.0 38920] eros} 205065] 185015} iae575| 768.60 65] 4nong0] 457.94 286.36 2539] ars] Lotass asi7e] 43876] 0695] a7oss2] ante xsscs3] —ay7050] 211292] 793353 929523] 4n3sa5} sox.98! sssin90) 1622298 9iz6s9} 3.73300] azosi27| s5,aso2 aosio76| 15,0042] 13,543.06] 41,16029} 39,034.79 room} aaie03] ranor| 573851 azsa} rosa} reoo| zazs3] 6792.06 10617 56.08 4649] 37025 10878 esas] mga] aasas] sare u7ses9} — yaraar] 1.46753] 610876 gas7e} 111928] aaa] 790082) 7.62029 598.93, 55025] sone] 28293 ‘58.08 sors] 2aa5) 2392.46 1202.96 sss2] smu] 392583 xomn}| 49954} 196813] sases7] 5.26783, 7 : : 5473 - : sss2| 45473 3552 sass2} sru77|sariao] 37703] 167. soasa| 1909.65] soorsa| 528835 269.59 oss] sa} 505.27] aast0 | ma56) ata] ime] — 2079] uz} sang] asrs19] 2sai7s] 1azcea] 250.98] 2sazs9] sssz00| scsi esszs] sansa} 25759] ase.76] rane) —aso9s} aera] ssez00] ssoaae - - - 037 : - 037 (an e423] sano) asrsa9] asex76] 142499) —2o098| aseis9| ssszs7] 5.50273, 9330] sss} 966.65) —assas] 966.66] sao] asses] osses] — ss.88 siazsas | gs2407 1665490 | 32827.68 10s. oss, oss, 268 an as ow oa7 378 57 tc oss 038, 207 27 148 ow, oa7 371 575. 2. WICEL, Opp. SEEPZ Main Gote, Cental Road, Ander (f), Mumboi-400 093, India, Ts +91 22 6700 1000 | F: +91 22 2899 4404 | E: corparata@ecinls cm | wecamlinkacern |$0 22000 Cerlied Company | CINL74100MH1993°.C07536) ‘Camlin Fine Sciences Lid. Flot No. F/11 & F mal ml ie Scler GF Ca [Notes to standalone financial results for the quarter and year ended March 31, 2016 4 Treabove audited financial results were reviewed by the Audit Committee and have been considered and approved by the Boned of Director at ts mevting held on May 23,2016 2 Company has recommenced Re 0.45 per share dividend on 9,665 80 equity shares of Re. 1 each wich shall besubjec to sharehaliers’ approval atthe ensuing Annual General Meeting. Proposed amount of dividend for distribution is Re 435 lakh, 3 During the second quarter of this financial year, the insuranceclaim relating tthe fire which occurred in financial yen 13-14 was sted by the insurance company. Raged on the sotlement ‘exceptional tem inciades a charge of R587 lakh recorded during tat quarter. 4 During the quarter under raview the company has allotted 3.35500 equity shares af Rs-1/- each ata price of Rs 67/- per share to its employoas unsar the Employees Stock Option Scheme 2014 (ESOP 2014) (Tranche VI}. Accordingly the paid up capital ofthe company stands increased from Rs. 958.88 laths to Rs. 905.66 ks. '5 Company's operations constitte a single business sagment business a Fine Chemicals side Indie for quarter ended March 2016 R1800.89 lakh and. 9096.75 lakh sespectvely 1 Revenues within and outside India for year encled March 2016 R&437.09 lakh and R6A8214.0 lakh respectively 6 On 4th May, 2016, CHS ANTIOXIDANTES DE MEXICO S.A. DEC.V,, Company's Wholly Owresd Sulsidiary in Mexico has acquired 65% stake in DRESEN QUIMICA S.A Pi.de CV, Mexico along ‘with ts group companies. 2 For both standalone as wel as consolidated results, the figures of last quarter ae the balancing figures between audited Figures in repect ofthe fll financial year and the published yenr to date figures ‘upto the tire quarter of errent financial year {3 Bgues for previous periods have been regrouped rearranged wherever necessary. Notes to consolidated financial results for the year ended March 31,2016 1 The above audited financial results wore reviewed by the Audit Committee and have heen considered an approved by the Board of Hiractor a its meeting held on May 23,2016, 2 The Company's operations consttutea single business segment busines in Fine Chemicals. FOR CAMLIN FINE SCTENCES LIMITED. ee rth Date: May 24,2016 Ashish, Dandekar Moneging Ditector SG ailigh rane aes weno ce eae T: +91 22 6700 1000 | F: +91 22 2832 4404 | E corporata@eomlinfs.com | worermmlinf.com Camlin Fine Sciences Ltd. Fine Sciences 180 22006 Cerifed Company | CIN L74100MH1999PLC075341, Statement of Assets & Liabilities 1, Murbol-400 099, tna @eintaldy seaie wamncurans Rp ae ENN SSB he | aa S if Fess, | aon Rae Pp Rita. | Audited 5] Augied 1. EQUITY AND LIABILITIES 1sharehotdere’ ands (@) Share Capitt sescs| onan] 666] 5888 ()) Reserve & Siaplue nis36] _garc07 | s66s490| 1259765 Sub Total-Shareholder' funds] 103502] 9.79295| 17460156] 1349651 2}Non- Curren abilities le) Long tenn Bomowings zooss| grist] 2440] 2068 (o) Deferred ax iites waist] saan] aman | aaa () Long tem provision ws2| taro] se5.25| 14700 Sub Totat-Non-current abites]| _asn0a5[ 39265] _aasasr | __aazzer |curent abitities ls) Stor tec Borrowings nasrss3| 970018] usmaas| 12087 o) Trade payables emizs| 9c) 9smas| 100.48 Jo) Oner current Hisies zasias| asst] 27052] 19st (a) Short tem provisions siom| 75770] asz90| _asa02 Sub Tota-Coneni abilities] 25,69751| _aus0sa9[ 2750454) 26 1snan TOTALFQUTVANDHiAwnITES| wsaaan| sisva7e| seaman | _aaaorss 1, |assers 1 Non-curent assets a) Fixed Asoots saos36| 632012] 1653386) 10.9a459 te) Non-curent Investments eso] 8777] 0942) 10905 (o) tong term loans and advances tase] e523] ssn] 20.76 (a) Defered tex asoss a 7 1assza | 16i8.71 Sub Total-Nos-current assets) 1059038) 7542 Tsosaat 2|curentassets Ny tenors 1180556] sooes0] arasiss| 1.63807 (@) Trade receivables saw) rzomo1) 754806) 1134150 fe) Cas ad Bank lances asmri| rzo1] —ra6064| 192604 a) Short term oans and advances aware] —aaoase] —ar988| 061 (0) Other current asets | aztas| —samac| —29m25| arse Sub Totai-Coneniasees| —2735230| 7.2567] 2esrs7[ 2980948 ToraLassers| sszinee | sasra70| saaroar| 296759 lace: Mumbai Date: May 23,2016 FOR CAMLIN FINE SCIENCES LIMITED Ab A Ashish, Dandekar Managing Director - Camlin Fine Sciences Ltd. = Calin, tener svie wets oy an Cam, cine tule or 40 095, Pele mae att oetesmeiant| ctewaeee een Fine Sele 1SO 22000 Cexfified Company | CIN L.74100MHi 993PLCO75261 Eivac of Statement of Standalone & Consolidated Audlted Fnanchal Reals Yor the Gaaver and Weur Ended Murch 5,56 (Rein Lak pag eee oo "Plc ice oat Operations et Tear] waa] Lanse tamu] A748 2 [rte fom orn otto sertox seoas| eso | “asmi6 ani] 350418 » pecebeneereetaacetmion | a] an] ao coe |e eee aa » Sengceertainsy ere «ees sowzsr]} 550073 uses] ssa niaas6 tepses0| 1252700 ‘The above information the dete format of anders forthe quarter and year ended March 31,2016 Hed with she tock changes under Regulation S$of the SEBI lng Obgations and Disclosure Requirements) Roglation, 205. Th fl format othe ated rept forthe quarter and yen ended Mach 3, 016 areavalale fon the compaay/e webeie,woeve coming com and the Sec Exchange webste ie, wr becindincom and www.aelndiacen Places Dtunbe OR CAMLIN FINESCIENCES LIMITED Date May 28 2016, Devegtigiitt Ashish § Dandekar Managing Direc a Camlin Fine Sciences Ltd. Se Cara tal ence ec eel ct eae Fine Sciences T: +91 22 6700 1000 | F: +91 22 289 4604 | E corporotadiearin’s com | wwrwcomlings com $0 22000 Ceried Company CNL 7410QMH1993°.C075341 (as on the date of adoption of accounts ~ 23 May, 2016) Name of the Company ‘Camiin Fine Sciences Limited 2. | Annual Standalone financial statements for the yeor ended 31% March, 2016 3. | Type of Audit observation Unqualified report Emphasis of Matter: See Emphasis of Matter section of Audit Report on the Financial Results 4, | Frequency of observation For Camin Fine Sciences td. Arte Ad Ashish S. Dandekar Managing Director For Camlin Fine Sciences lid. Sharad-M. Kulkarni Chairman of Audit Committee Place: Mumbai Date : 23 May, 2016 Since 2015 For Camlin Fine Sciences Ltd. se Dattatraya R. Puranik Executive Director & Chief Financial Officer For 8. K. Khare& Co, Chartered Accountants Firm Reg. No, 105102W earl cheesey Partner Membership No.105731 B. K. KHARE & Co. CHARTERED ACCOUNTANTS: T 91 022.22000607/731816960 491 022 66315898/96 F +91 022.2900 3478 E lnfo@ok«nareco.com 706/708, Sharda Chambers Now Marine Lunes, Mumbai - 400 020, Inia Auditor’s Report on the Standalone Results of the Company for the quarter and year ended March 34, 2016 pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 To ‘The Board of Directors, Camlin Fine Sciences Limited 4. (a) We have audited the standalone financial results of Camlin Fine Sciences Limited (the Company) for the quarter and year ended March 31, 2016, attached herewith, being submitted by the Company pursuant tothe requirement of Regulation 33 of SEBI (Listing Obligatons and Disclosure Requirements) Regulations, 2015. The quarterly standalone financial results for the quarter ended March 31, 2016 are the derived figures between the aueited figures for the year ended March 31, 2016 and the published year-to-date figures up to December 31, 2015, being the end of the previous quarter of the current financial year, which were subjected lo a limited review. (b) The standalone financial results for the quarter ended March 31, 2016 have been prepared on the basis of the interim standalone financial statements for the nine-month period ended December 31, 2015, the audited standalone financial statements ‘or the year ended March 31, 2018, and the retevant requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2016, are the responsibilty of the Company's management and have been approved by the Board of Directors of the Company. The standalone interim financial statements for the nine-month period ended December 31, 2018 and the audited standalone financial statements forthe year ended March 31, 2016 have been prepared in accordance with the recognition and measurement principles laid down in ‘Accounting Standard 25 ~ ‘interim Financial Reporting’ and the accounting standerds specified under Section 133 of the Companies Act, 2013, respectively, read with the relevant rules issued thereunder, and other accounting principles generally accepted in India. {c) Our responsibilty is to express an opinion on these standalone financial results based on our review of such interim standalone financial statements and audit of the standalone financial statements as at and for the year ended March 31, 2018, 2, We conducted our auait in accordance withthe auciting standards generally acoepted in India. Those standards require that we plan and perform the aucit lo obtain reasonable assurance about whether the standalone financial results are ffee of material misstatements. An aut includes examining, on a test basis, evidence supporting the amounts disclosed inthe financlal results, An audit also includes assessing the accounting principles used and the significant estimates made by management. We believe that our audit provides a reasonable basis for our opinion. ae Pune Bengaluru Now Dathi +91 020 60801008/6/778 T491 0041108957 T+91 ot 4905 7624 91 020 ese66902102020341, E bikbengalurueebk&harece.com Ebikkdethi@bkkharoco.com E bikpune@oK«hareco.com 101, Money Camber, A 4, Westend, Hotel Swaroop, 4th Flow, ‘st Foo, # 6 KH, Road, Flag Tula Ram Mara, Lane No.10,Prabnat Road, ‘Shanthinagar, Now Det - 110021, Erandwane, Pune - 417 004, Indl ‘Bengaluru ~ 580027, Ina naa B. K. KHare & Co. CHARTERED ACCOUNTANTS 3. In our opinion and to the best of our information and according fo the explanations given to us these quarterly and annual standalone financial results for the quarter and year ended March 31, 2016: (i) are presented in accordance with the requirements of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2016 in this regard; and (i) give @ true and fair view of the standalone net profit and other financial information of the Company for the quarter and year ended on March 31, 2016. 4, We draw attention to the Company's investment of Rs 56.01 lakhs in and loans of Rs 160.33 lakhs gi to is subsidiary company recoverability of which is based on successful implementation of management's future plans in respect of the subsidiary, Our conclusion is not modified in respect of this matter. For BK. Khare & Co, Chartered Accountants Firm Registration No, 105102W Himanshu Errdey Partner Membership No. 105731 Mumbai, May 23, 2018 Cami Fine Sciences 1@ Sciences Ltd. S Carlin rete tins. weet, on. Str Nain Go, cana ocd Aches Ts +91 22 6700 1000 | F: +91 22 2832 4404 | E: corpoxcte@ecmlings com | waevecamlinfs. com. 150 22000 Cerifed Company N74 ]OOMH993PLCO75361 {As on the date of adoption of accounts ~ 23 May, 2016) Mueboi-400 098, India J. | Name of the Company ‘Camiin Fine Sciences Limited 2, | Annual Consolidated financial statements for the year ended 31 March, 2016 3, | Type of Audi observation 4 | Frequency of observation For Camin Fine Sciences Lid. Arb tu Ashish . Dandekar Managing Director For Camiin Fine Sciences Ltd. Sharad M.Rulkarni” Chakman of Audit Committee Place: Mumbai Date : 23% May, 2016 For Camlin Fine Sciences Lid. oe Dattatraya R. Puranik Executive Director & Chief Financial Officer For B. K. Khare& Co. Chartered Accountants Firm Reg. No. 105102W Himanshu cneheey Partner Membership No.105731 B. K. KHare & Co. CHARTERED ACCOUNTANTS. +91 022 22000607/7318/6360 4-91 022 66315895038 +91 022 22003476 Einfo@ oeknareco.com ‘708/708, Sharda Chambers New Mari Auditor's Report on the Consolidated Results of the Company for the qlaiedf sire yes? GRGee”* March 31, 2016 pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 To ‘The Board of Directors, Camilin Fine Sciences Limited 1. (a) We have audited the consolidated financial results of Camlin Fine Solenoes Limited (the Holding Company’) and its subsidiary companies (the Holding Company and its subsidiaries are referred to as ‘the Group) and Its associates for the year ended on March 31, 2016, attached herewith, being submitted by the Company pursuant to the requirement of regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2076. The quarterly consolidated financial results for the quarter ended March 31, 2018 are the derived figures between the audited consolidated figures for the year ended March 31, 2018 and the published consolidated year-to-date figures up to December 31, 2015, being the end of the previous quarter of the current financial year, which were subjected to a limited review. (b) ‘The consolidated financial results for the quarter ended March 31, 2016 have been prepared on the basis of the interim consolidated financial statements for the nine-month period ended December 31, 2015, the audlted consolidated financial statements for the year ended March 31, 2016, and the relevant requirements of Regulation 33 of the SEB! (Listing Obligations and Disclosure Requirements) Regulations, 2015, are the responsiblity of the Company's management and have been approved by the Board of Directors of the Company, The consolidated interim financial statements for the nine-month period ended December 31, 2015 and the audited consolidated financial statements for the year ended March 31, 208 have been prepared in accordance with the recognition and measurement principles laid down in ‘Accounting Standard 25 ~ “interim Financial Reporting” and the accounting standards specified under Section 133 of the Companies Act, 2013, respectively, read with the relevant rules issued thereunder, and other accounting principles generally accepted in India, (¢) Our responsibilty is to express an opinion on these consolidated financial results based on our review of such interim consolidated financial statements and audit of the consolidated financial statements as at and for the year ended March 31, 2076, 2, We conducted our auc in accordance with the auditing standards generally accepted in India. Those standards require that we plan and perform the audit fo obtain reasonable assurance about whether the standalone financial results are free of material misstatements. An aucit includes examining, on a {est bas's, evidence supporting the amounts disclosed in the financial results. An audit also Includes assessing the accounting principles used and the significant estimates made by management. We believe that our audit provides a reasonable basis for our opinion. ae Pune Bengaluru New Dethi +91 020 6060100506718 T+-91 90 41105357 T+91 011 4162 6260 +91 020 2ssesasa/s2e26541 E bkkbengaluw@bkihareca.com E bikdelhi@bkinareco.com E bikpuna@okknareco.com 101, Money Chambers, | 107, Siddharth Chamoors, Hotel Swaroop, 4th Floor, st Floor, #6 K. H. Road, | Near iT Gato, Lane No.10, Prabhat Road, Shanthinager, Kalu Sarai, Hau Khas, Erandwane, Pune -411 004, Inia. Bengaluru - 560027, India New Delhi- 110.016. India, B. K. KHARE & Co. CHARTERED ACCOUNTANTS 3. (a) We did not aucit the financial statements of 4 subsidlaries included in the consolidated financial results, whose financial statements reflect total assets (before consolidation adjustments) of Rs 20,374.58 lakhs as at March 31, 2018 as well as total revenue (before consolidation adjustmonts) of Rs 24,868.00 for the year ended March 31, 2076. The consolidated financial results also include the Group's share of net profi of Rs 0.37 lakhs for the year ended March 31, 2016 (before consolidation adjustments) in respect of 2 of its associates, whose financial statements have not been audited by us. These financial statements and other financial information have been audited by other auditors whose reports have been furnished to us, and cour opinion on the consolidated financial results forthe quarter and year ended March 31, 2016, to the extent they have been derived from such financial statements is based on soley on the report of such other auctions We did not audit the financial statements of 1 subsidiary included in the consolidated financial results, whose financial stalements reflect total assets (before consoldation adjustments) of Rs 1.91 lakhs as at March 31, 2016 which had eamed no revenue for the year ended March 31, 2016. These financial statements and other financial information are unaudited and have been furnished to us by the menegement, and our opinion on the consolidated financial results to the extent they have been derived from such financial statements is based solely on such unaueited financial statementsfinancial information. incur opinion and according to the information and explanations given fo us by the Management, these financial statementsnancial information are not material to the Group. ) 4. In our opinion and to the best of our information and according to the explanations given to us these consolidated financial results (i) Include financial results of the following entities (subsidiaries and associates) included in the consolidation a} CFCL Mauritius Private Limited (subsidiary) b) CFS do Brasil Industria, Comercio, Importacao ¢ Exportacao de Aditivos Almenticos Lida, (subsidiary) ©) Solentus North America Ino (subsidiary) }) CFS Europe S.p.A. (subsidiary) @) CFS North America LLC (subsidiary) {) CFS Antoxidantes De Mexico S.A. De C. V. (subsidiary) ). Fine Lifestyle Brands Limited (associate) h)_ Fine Lifestyle Solutions Limited (associate) B. K. KHare & Co. CHARTERED ACCOUNTANTS {i) are presented in accordance withthe requirements of regulation 23 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2048 inthis regard; and {il) give a true and fair view ofthe net profit and other financial information of the Company for the ‘uartes and year ended on March 31, 2016. For B. K. Khare & Co, Chartered Accountants Firm Registration No. 105102 Himanshu Cr ¢ Partner Membership. No, 105731 Mumbai, May 23, 2016

You might also like